Sutro Biopharma Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Sutro Biopharma stock ranges from a low of $0.80 to a high of $15. The average analyst price target of $3.83 forecasts a 396.11% increase in the stock price over the next year.

Price Target: $3.83 (+396.11%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$0.80	$3.83	$2.00	$15
Change	+3.63%	+396.11%	+159.07%	+1843.0%

Analyst Ratings

The average analyst rating for Sutro Biopharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	1	1	1	1	1	1
Buy	2	2	1	1	1	1
Hold	3	4	4	4	4	5
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	7	8	7	7	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $4 → $3	Hold	Maintains	$4 → $3	+288.60%	Aug 12, 2025
Edward Tenthoff Piper Sandler	Piper Sandler	Hold → Buy Upgrades $2	Hold → Buy	Upgrades	$2	+159.07%	Jun 16, 2025
Tazeen Ahmad B of A Securities	B of A Securities	Sell Maintains $1 → $0.8	Sell	Maintains	$1 → $0.8	+3.63%	May 19, 2025
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $2	Hold	Reiterates	$2	+159.07%	Apr 29, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades $12 → $2	Strong Buy → Hold	Downgrades	$12 → $2	+159.07%	Mar 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

59.56M

from 62.04M

-4.01%

from 62.04M

Revenue Next Year

45.71M

from 59.56M

-23.24%

from 59.56M

EPS This Year

-2.00

from -2.96

EPS Next Year

-1.33

from -2.00

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	42.72M	61.88M	67.77M	153.73M	62.04M	59.56M	45.71M	46.11M
Revenue Growth	-0.03%	44.84%	9.52%	126.84%	-59.64%	-4.01%	-23.24%	0.88%
EPS	-0.99	-2.29	-2.35	-1.78	-2.96	-2.00	-1.33	-1.57
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	79.7M	72.2M	80.6M
Avg	59.6M	45.7M	46.1M
Low	16.7M	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	28.5%	21.2%	76.3%
Avg	-4.0%	-23.2%	0.9%
Low	-73.1%	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.12	-0.71	-0.93
Avg	-2.00	-1.33	-1.57
Low	-2.81	-2.29	-2.12

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.